PDF | On Jun 23, , Jessica L Morris and others published FIGO’s updated recommendations for misoprostol used alone in gynecology and. In , the International Federation of Obstetrics and Gynecology (FIGO) produced a chart detailing recommended dosages of misoprostol. These dosage guidelines are produced by FIGO and WHO. Recommended doses of Misoprostol (Cytotec®) are provided in this site along with instructions for.
|Published (Last):||3 May 2010|
|PDF File Size:||16.21 Mb|
|ePub File Size:||15.30 Mb|
|Price:||Free* [*Free Regsitration Required]|
Postpartum Haemorrhage Initiative
misoprostok Share this page Facebook Share this page on Twitter Print this page. PPH leading to unnecessary deaths. Missed abortion c,2 1st Trimester.
Safe single doses of vaginal misoprostol for producing uterine contractions at various gestations.
Advocating for improved access to postpartum hemorrhage management: This independent site has been set up to distribute dosage guidelines for the use of misoprostol in obstetrics and gynaecology. Skip to main content. Pregnancy Termination a,b,1 1st Trimester.
Project materials FIGO’s advocacy pack: The most common cause of PPH is poor contraction of the uterus uterine atony. Induction of labour h,2,9 25mcg vaginally 6-hrly or 25mcg orally 2-hrly Do not use if previous caesarean section. Most effective when used 48h after mifepristone mg.
Jessica MorrisProject Manager What is postpartum haemorrhage? Incomplete abortion a,2,3,4 1st Trimester. Follow the dosage regimes carefully and do not exceed those doses.
Do not use if previous caesarean section. A misoprosto description of the treatment can also be found here. The correct dosage varies greatly according to gestation, indication and route of administration — using the correct dosage is vital for success and to prevent complications.
They are based on those originally produced by the Bellagio group in but updated regularly since. Human Reproduction, ; Kapp et al. Jessica MorrisProject Manager. Intrauterine fetal death f,g,1,5,6. Download the above chart in PDF format click here. Lancet, ; Sheldon et al. The aim of the survey was also to establish any challenges to implementing evidence-based practice, in order to further support FIGO Member Associations in working towards their maternal health goals.
Cervical ripening for surgical abortion a,d. Where oxytocin is not available or storage conditions are inadequate.
A full pictorial guide on how to safely make up a ml batch of a 1 microgram per ml solution of misoprostol for oral administration can be found here. Treatment of PPH with misoprostol, Usability website access settings. Leave to work for 2 weeks unless heavy bleeding or infection.
Article on misprostol recommendations.
For fetal death in the third trimester see ‘Induction of Labour’ below. Give 2 doses and leave to work for weeks unless misopfostol bleeding or infection. Instructions on preparing the oral solution can be found here. Postpartum Haemorrhage PPH is the leading cause of maternal mortality in low-income countries. Can use also for insertion of intrauterine device, dilatation and curettage and hysteroscopy.
A detailed document on this topic is available here Intrauterine fetal death f,g,1,5,6 wks: Misoprostol figgo a very powerful stimulator of uterine contractions in late pregnancy and can cause fetal death and uterine rupture if used in high doses. A simplified dosage chart for non-doctors is also available here.
A detailed document on this topic is available here.
Reduce doses in women with previous caesarean section. PPH treatment k,2,10 mcg sublingually misoprotsol dose Where oxytocin is not available or storage conditions are inadequate. A detailed description of the treatment can also be found here Cervical ripening for surgical abortion a,d weeks: Exclude second twin before administration.
Dosage Guidelines – Misoprostol
Induction of labour h,2,9. Gynuity have a wide range of useful misoprosyol available regarding misoprostol use which can be found here. If a higher dose than this is used, then uterine hyperstimulation with uterine rupture or fetal distress might be the result.
Conducted a review of misoprodtol latest evidence which led to updating of the chart Conducted more than 40 expert panel sessions to disseminate the latest clinical information on PPH management Launched a survey with our member societies to find out more about the current status of country-level guidelines on PPH management FIGO’s member society survey In FIGO conducted a fjgo of our member societies, to find out about their national guidelines for PPH, and inclusion of key PPH medicines on essential medicines lists EMLs.
Maternal Health Task Force blog.